Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis

BACKGROUND: We conducted a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials of anti-dementia drugs plus antipsychotics for schizophrenia. METHODS: Primary outcomes of efficacy and safety included improving overall symptoms (Positive and Negative Syndrome Sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Taro, Ikuta, Toshikazu, Oya, Kazuto, Matsunaga, Shinji, Matsuda, Yuki, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070030/
https://www.ncbi.nlm.nih.gov/pubmed/29762677
http://dx.doi.org/10.1093/ijnp/pyy045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070030/
https://www.ncbi.nlm.nih.gov/pubmed/29762677
http://dx.doi.org/10.1093/ijnp/pyy045

Ejemplares similares